Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Issues reported with supply of lactating cow intramammary antibiotics
Ubro Yellow Milking Cow Intramammary Suspension is one of the products to be suspended.

VMD updates list of available products

The Veterinary Medicines Directorate (VMD) has reported supply problems with certain lactating cow intramammary antibiotics.

The following is a list of lactating cow intramammary antibiotics that Marketing Authorisation Holders (MAHs) have noted availability problems for, along with anticipated resolution dates for each product:

Product Anticipated resolution date
Synulox Lactating Cow Intramammary Suspension (42058/4143) First quarter of 2021
Tetra-Delta Intramammary Suspension (42058/4152) First half of 2021
Ubro Yellow Milking Cow Intramammary Suspension (08327/4305) Product discontinued – no return date
Multiject IMM Intramammary Suspension (02000/4062) February 2021
Albiotic 330mg/100mg Intramammary Solution (30282/4035) December 2020
Mastiplan LC, 300mg/20mg Intramammary Suspension (01708/4534) End of November 2020
Cobactan MC Intramammary Suspension for Lactating Cows (01708/4444)* December 2020
Combiclav Intramammary Suspension for Lactating Cows (02000/4424) January 2021
Cefimam LC, 75 mg Intramammary Ointment for Lactating Cows (02000/4387)* product discontinued – no return date

These lactating cow intramammary products have been reported as available for veterinary surgeons to purchase:

Ubropen 600 mg Intramammary Suspension for Lactating Cows (42810/4000)
Ubrolexin Intramammary Suspension for Lactating Dairy Cows (08327/4306)
Procapen Injector 3g intramammary suspension for cattle (24745/4023)
Orbenin L.A. 200mg Intramammary Suspension (42058/4090)
Pathocef 250mg Intramammary Suspension (42058/4094)*

Please note: VMD states that the products marked with a '*' are defined as a Highest Priority Critically Important Antibiotics for human medicine and, under the Red Tractor farm assurance scheme for beef and dairy, should be used as a last resort and supported by sensitivity and/or diagnostic testing.

For further details of the supply situation for individual UK-authorised products, please contact the MAH or a wholesale dealer.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.